Holen Sie sich die Stockscreener-App
18.66
4.36%
-0.85
Handel nachbörslich:
18.66
Schlusskurs vom Vortag:
$19.51
Offen:
$19.25
24-Stunden-Volumen:
304.19K
Relative Volume:
0.94
Marktkapitalisierung:
$638.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.05M
KGV:
-7.1134
EPS:
-2.6232
Netto-Cashflow:
$-68.97M
1W Leistung:
-11.90%
1M Leistung:
-10.67%
6M Leistung:
-34.62%
1J Leistung:
-13.21%
1-Tages-Spanne:
$18.55
$19.49
1-Wochen-Bereich:
$18.55
$21.50
52-Wochen-Spanne:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Firmenname
Arrivent Biopharma Inc
Sektor
Branche
Telefon
240-780-6356
Adresse
18 CAMPUS BLVD., NEWTOWN SQUARE
Vergleichen Sie AVBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
18.66 | 715.92M | 0 | -81.05M | -68.97M | -2.6232 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-03-20 | Eingeleitet | B. Riley Securities | Buy |
| 2025-03-10 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-02-20 | Eingeleitet | Citigroup | Buy |
| 2024-02-20 | Eingeleitet | Goldman | Buy |
| 2024-02-20 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Arrivent Biopharma Inc Aktie (AVBP) Neueste Nachrichten
Why is ArriVent BioPharma Inc. stock attracting strong analyst attentionRetirement Planning Insights For Fast Growth - jammulinksnews.com
What is the risk reward ratio of investing in ArriVent BioPharma Inc. stockBest Dividend Data Feed To Watch Now - jammulinksnews.com
When is ArriVent BioPharma Inc. stock expected to show significant growthPost Market Alerts For Every Investor - jammulinksnews.com
Can trapped investors hope for a rebound in ArriVent BioPharma Inc.Quick Profit Setup with Signal Forecast - Newser
Predicting ArriVent BioPharma Inc. trend using moving averagesImmediate Entry Point Prediction Strategy - Newser
Comparing ArriVent BioPharma Inc. in custom built stock radarsFree Weekly Stock Opportunity Radar Scanner - Newser
News impact scoring models applied to ArriVent BioPharma Inc.AI Short-Term Gain Forecast with Data - Newser
ArriVent BioPharma Inc. stock trend forecastBuy Signal System Based on Price Action - Newser
ArriVent BioPharma Inc. Earnings Report Breakdown: What Investors Should KnowMachine Learning Intraday Signal Forecast - Newser
Will ArriVent BioPharma Inc. price bounce be sustainableFree Entry and Exit Strategy Optimizer Tool - Newser
Sentiment analysis tools applied to ArriVent BioPharma Inc.Conservative Asset Allocation Risk Analysis - Newser
What makes ArriVent BioPharma Inc. stock price move sharplyFree Watchlist for Low Risk High Return - Newser
Tools to monitor ArriVent BioPharma Inc. recovery probabilityDaily Trade Setup Forecast with Confidence - Newser
Does ArriVent BioPharma Inc. stock perform well during market downturnsTop Growth Planner For Every Investor - jammulinksnews.com
Understanding ArriVent BioPharma Inc.’s price movementSecure Buy Strategy Based on Risk Parameters - Newser
Trend analysis for ArriVent BioPharma Inc. this weekStable Profit Zone and Loss Control Analysis - Newser
How ArriVent BioPharma Inc. stock performs during market volatilityFree Expert Verified Stock Trade Ideas - Newser
ArriVent BioPharma Inc. stock prediction for this weekFree Smart Trade Plans With Risk Protection - Newser
Using RSI to spot recovery in ArriVent BioPharma Inc.Free Secure Capital Picks With Upside Potential - Newser
why arrivent biopharma inc. stock attracts strong analyst attentionBuy Point Strategy with Profit Protection - Newser
Why ArriVent BioPharma Inc. stock attracts strong analyst attentionTechnical Setup Guide for Daily Watchlist - Newser
How Interest Rate Changes Impact ArriVent BioPharma Inc. Stock PerformanceRisk Limited High Gain Trades - metal.it
Is ArriVent BioPharma Inc. a growth stock or a value stockAchieve consistent double-digit returns - jammulinksnews.com
Using data models to predict ArriVent BioPharma Inc. stock movementFree Weekly Hot Picks With Buy Confidence - Newser
ArriVent BioPharma Inc. stock trend forecast Free Reversal Alert Based on RSI Indicator - Newser
Using data models to predict ArriVent BioPharma Inc. stock movement Low Risk Trade Timing with Analysis Metrics - Newser
ArriVent BioPharma Inc. recovery potential after sell off Price Action Based Buy Zone Forecast - Newser
What institutional investors are buying ArriVent BioPharma Inc. stockFree Daily Trading Room Entry - jammulinksnews.com
What is ArriVent BioPharma Inc. company’s growth strategyBuild a winning investment strategy - jammulinksnews.com
How strong is ArriVent BioPharma Inc. company’s balance sheetFree Stock Market Trend Analysis - jammulinksnews.com
How many analysts rate ArriVent BioPharma Inc. as a “Buy”Exceptional trading performance - jammulinksnews.com
Is ArriVent BioPharma Inc. stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
ArriVent BioPharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySteady Profit Stock Forecasts - Newser
Is ArriVent BioPharma Inc. stock a growth or value playLow Risk Trade Timing Signals - Newser
ArriVent BioPharma Eyes Early 2026 for Phase 3 Lung Cancer Drug Data - MSN
ArriVent BioPharma Inc. Stock Analysis and ForecastExceptional market positioning - PrintWeekIndia
What risks could impact ArriVent BioPharma Inc. stock performanceLightning-fast capital gains - jammulinksnews.com
Lifesci Capital Issues Positive Estimate for AVBP Earnings - Defense World
Can ArriVent BioPharma Inc. stock recover from recent declineUnprecedented market success - jammulinksnews.com
What analysts say about ArriVent BioPharma Inc. stockExplosive returns - PrintWeekIndia
Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Arrivent Biopharma Inc-Aktie (AVBP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LaChapelle Robin | Chief Operating Officer |
Sep 19 '24 |
Option Exercise |
3.28 |
27,566 |
90,481 |
124,583 |
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):